This 1 hour, 9-minute presentation evaluates medications and evidence-based guidelines used to treat allergic rhinitis, COPD, and asthma.
Choose video or audio delivery. Video: Video format requires Google Chrome; each video purchase can be viewed two times within 6 months of purchase. Rewind and fast forward not available. Audio: Each audio purchase is accessible for 2 years from the date of purchase.
After completion of this activity, participants should have a better understanding of:
- Evaluation of medications, evidence based guidelines used to treat allergic rhinitis
- Review evidence based guideline used to manage patients who have COPD and asthma
- Review medications/classes used to manage patients who have COPD and asthma
- The content in all APEA review courses, CE offerings and clinical resources reflects evidence-based practice.
This activity is approved for 1.25 contact hour(s) (which includes 1.0 hour(s) of pharmacology)
TIME TO COMPLETE
1 hour 9 minutes
Reviewed December 2018; Originally released April 2016
Advanced Practice Education Associates (APEA) is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 100820. This activity is approved for 1.25 contact hour(s) (which includes 1.0 hour(s) of pharmacology). Program ID #2016-02-06P.
This course is taught by Amelie Hollier, DNP, FNP-BC, FAANP, a nationally certified family nurse practitioner and one of the most dynamic speakers in the healthcare industry. You will love her informative style, personable delivery, and real-life anecdotes.
APEA MOBILE App
APEA Mobile is a free app that can be downloaded from the Apple App Store or Android store. Purchases must be made through apea.com and will automatically be synced to your app. Content downloaded to your device from the app can be accessed at any time, even without an internet connection.
Minimum space required: Each video section may take up to 150 MB.
iPhone versions 5 and above and iPad Air and Mini and above.